VBI Vaccines Inc. (VBIV)
VBI Vaccines Statistics
Share Statistics
VBI Vaccines has 28.68M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 28.68M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0% |
| Shares Floating | 26.73M |
| Failed to Deliver (FTD) Shares | 269.63K |
| FTD / Avg. Volume | 3.17% |
Short Selling Information
The latest short interest is -, so null% of the outstanding shares have been sold short.
| Short Interest | - |
| Short % of Shares Out | null% |
| Short % of Float | null% |
| Short Ratio (days to cover) | null |
Valuation Ratios
The PE ratio is null and the forward PE ratio is null.
| PE Ratio | null |
| Forward PE | n/a |
| PS Ratio | 1.05 |
| Forward PS | null |
| PB Ratio | 1.22 |
| P/FCF Ratio | null |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for VBI Vaccines.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.48, with a Debt / Equity ratio of null.
| Current Ratio | 0.48 |
| Quick Ratio | 0.37 |
| Debt / Equity | null |
| Debt / EBITDA | -0.99 |
| Debt / FCF | -0.86 |
| Interest Coverage | null |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $66.27K |
| Profits Per Employee | $-708.67K |
| Employee Count | 131 |
| Asset Turnover | 0.1 |
| Inventory Turnover | 1.71 |
Taxes
| Income Tax | 1.82M |
| Effective Tax Rate | -1.96% |
Stock Price Statistics
The stock price has increased by -88.95% in the last 52 weeks. The beta is 2.17, so VBI Vaccines's price volatility has been higher than the market average.
| Beta | 2.17 |
| 52-Week Price Change | -88.95% |
| 50-Day Moving Average | 0.35 |
| 200-Day Moving Average | 0.55 |
| Relative Strength Index (RSI) | 21.98 |
| Average Volume (20 Days) | 8.5M |
Income Statement
In the last 12 months, VBI Vaccines had revenue of 8.68M and earned -92.84M in profits. Earnings per share was -5.96.
| Revenue | 8.68M |
| Gross Profit | -5.82M |
| Operating Income | -55.31M |
| Net Income | -92.84M |
| EBITDA | -53.32M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -5.96 |
Balance Sheet
The company has 23.68M in cash and 53.04M in debt, giving a net cash position of -29.36M.
| Cash & Cash Equivalents | 23.68M |
| Total Debt | 53.04M |
| Net Cash | -29.36M |
| Retained Earnings | -582.45M |
| Total Assets | - |
| Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was -60.88M and capital expenditures -867K, giving a free cash flow of -61.75M.
| Operating Cash Flow | -60.88M |
| Capital Expenditures | -867K |
| Free Cash Flow | -61.75M |
| FCF Per Share | -3.97 |
Margins
Gross margin is -66.98%, with operating and profit margins of -637.08% and -1069.29%.
| Gross Margin | -66.98% |
| Operating Margin | -637.08% |
| Pretax Margin | -1069.29% |
| Profit Margin | -1069.29% |
| EBITDA Margin | n/a |
| EBIT Margin | -637.08% |
| FCF Margin | -711.24% |
Dividends & Yields
VBIV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for VBIV.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Apr 12, 2023. It was a backward split with a ratio of 1:30.
| Last Split Date | Apr 12, 2023 |
| Split Type | backward |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | null |
| Piotroski F-Score | null |